Putative Antimicrobial Peptides Within Bacterial Proteomes Affect Bacterial Predominance: A Network Analysis...

Area of Science:

• Microbiology
• Bioinformatics
• Systems Biology

Background:

• The gut microbiome's composition is crucial for host health.
• Bacterial interactions within the gut are complex and not fully understood.
• Antimicrobial peptides (AMPs) are key components of innate immunity.

Purpose of the Study:

• To investigate the role of bacterial proteome-hidden antimicrobial peptide sequences (AMPs) in shaping gut microbiome composition.
• To develop a computational method for predicting bacterial dominance based on AMPs.
• To correlate predicted bacterial prevalence with actual abundance in gut microbiomes.

Main Methods:

• A network-based computational method, "Bacterial Wars," was developed to analyze sequence similarities of predicted AMPs.
• Protein sequences from the UniProt database were used for AMP prediction across different bacterial taxa.
• A "Die" score was calculated to quantify the competitive advantage of bacterial taxa based on their AMPs.
• The "Die" scores were correlated with bacterial abundance data from 16S rRNA and shotgun metagenomics datasets.

Main Results:

• The study identified putative AMP sequences within the proteomes of various bacterial taxa.
• The "Bacterial Wars" method and "Die" score effectively predicted bacterial predominance in silico.
• Calculated "Die" scores showed a significant correlation with the observed abundance of bacterial taxa in gut microbiomes across health and disease states.
• AMPs encrypted within bacterial proteomes were found to influence bacterial predominance in the gut environment.

Conclusions:

• Bacterial antimicrobial peptides (AMPs) play a significant role in determining the predominance of bacterial taxa within the gut microbiome.
• The developed "Bacterial Wars" method provides a novel approach to predict microbial community structure based on genetic determinants.
• Understanding AMPs' role offers potential therapeutic targets for modulating the gut microbiome in health and disease.